Showing results (231-240 of 274) with videos related to

Sort By:
Pageof 28
Journal of Clinical Medicine|April 14, 2026
Prognostic Impact of Qualitative and Quantitative Mitral Valve Calcification in Transapical Transcatheter Mitral Valve Replacement: A Sub-Analysis of the TENDER RegistryTillmann Kerbel, Liliane Zillner, Mirjam G Wild, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 12, 2022
Angiographic predictors of aberrant circumflex artery during cardiac catheterizationAndreas S Triantafyllis, Lokien X van Nunen, Pierluizi Lesizza, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 15, 2023
ShOckwave ballooN or Atherectomy with Rotablation in calcified coronary artery lesions: Design and rationale of the SONAR trialJohan Bennett, Keir McCutcheon, Koen Ameloot, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 19, 2023
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human studyMichael Haude, Adrian Wlodarczak, René J van der Schaaf, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II studyPatrick W Serruys, Scot Garg, Alexandre Abizaid, et al.
JACC. Cardiovascular Interventions|March 9, 2025
Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent: 2-Year Outcomes From BIOADAPTOR RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Eclinicalmedicine|December 18, 2023
First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Lancet (London, England)|January 18, 2006
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trialStefan Janssens, Christophe Dubois, Jan Bogaert, et al.
The Annals of Thoracic Surgery|February 27, 2025
Apical Access Management in Transapical Transcatheter Mitral Valve ReplacementTillmann Kerbel, Mirjam G Wild, Michaela M Hell, et al.
Journal of the American College of Cardiology|May 15, 2010
Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarctionChristophe Dubois, Xiaoshun Liu, Piet Claus, et al.
Pageof 28